Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “IGF1R”

85 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 85 results

Large-scale testing (Phase 3)Active Not RecruitingNCT06384547
What this trial is testing

A Randomized, Controlled, Safety and Tolerability Study of VRDN-001 in Participants With Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye Disease
Viridian Therapeutics, Inc. 231
Not applicableStudy completedNCT03498417
What this trial is testing

Anti-insulin-like Growth Factor-1 Receptor (IGF-1R) Antibodies in Graves' Disease and Graves' Orbitopathy

Who this might be right for
Graves OphthalmopathyGraves DiseaseAutoimmune Thyroiditis
University of Pisa 135
Large-scale testing (Phase 3)Study completedNCT04420481
What this trial is testing

Growth Hormone in Ischemic Heart Failure

Who this might be right for
Heart Failure, SystolicIschemic Heart Disease Chronic
Göteborg University 37
Not applicableStudy completedNCT00763607
What this trial is testing

Retrospective Study Evaluating IGF1R And p95HER2 as Prognostic Factors in Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
Armando Santoro, MD 454
Not applicableStudy completedNCT04767750
What this trial is testing

Role of LncRNA H19 in The Regulation of IGF-1R Expression

Who this might be right for
Hepatocellular CarcinomaType 2 DiabetesCancer
Mansoura University 101
Early research (Phase 1)Study completedNCT01536145
What this trial is testing

CP-751,871 Treatment For Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Pfizer 47
Early research (Phase 1)Ended earlyNCT00985374
What this trial is testing

A Multiple Ascending Dose Study of the mTOR Inhibitor (RAD001) in Combination With R1507 in Patients With Advanced Solid Tumors

Who this might be right for
Neoplasms
Hoffmann-La Roche 11
Early research (Phase 1)Study completedNCT00882674
What this trial is testing

Evaluate the Biological Activity of R1507 in Women With Operable Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 8
Testing effectiveness (Phase 2)WithdrawnNCT01013506
What this trial is testing

Phase 2, Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-sensitive Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Vanderbilt-Ingram Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00630552
What this trial is testing

QUILT-2.019: A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasMetastatic Pancreatic CancerPancreatic Cancer
NantCell, Inc. 138
Not applicableStudy completedNCT01365962
What this trial is testing

Biomarker in Tumor Tissue Samples From Patients With Rhabdomyosarcoma

Who this might be right for
Sarcoma
Children's Oncology Group 60
Testing effectiveness (Phase 2)Study completedNCT00887159
What this trial is testing

Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients With Extensive Stage

Who this might be right for
Extensive Stage Small Cell Lung CarcinomaRecurrent Small Cell Lung Carcinoma
National Cancer Institute (NCI) 168
Large-scale testing (Phase 3)Study completedNCT00924989
What this trial is testing

OSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical Carcinoma

Who this might be right for
Adrenocortical Carcinoma
Astellas Pharma Inc 139
Testing effectiveness (Phase 2)Ended earlyNCT00774878
What this trial is testing

Study of AVE1642 (IGF-1R/CD221) in Combination With Fulvestrant (Faslodex®) in Postmenopausal Patients With Advanced Hormono-dependent Breast Cancer

Who this might be right for
Breast Neoplasms
Sanofi 18
Testing effectiveness (Phase 2)Study completedNCT00831844
What this trial is testing

Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors

Who this might be right for
Adult RhabdomyosarcomaAdult Synovial SarcomaChildhood Hepatoblastoma+13 more
National Cancer Institute (NCI) 116
Early research (Phase 1)Study completedNCT01466647
What this trial is testing

The IGF-1R Inhibitor AXL1717 in Combination With Gemcitabine HCL and Carboplatin to Treat Non-small-cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
Axelar AB 12
Large-scale testing (Phase 3)Active Not RecruitingNCT06269393
What this trial is testing

IBI311 in Subjects With Steroid-resistant, Thyroid Associated Ophthalmopathy

Who this might be right for
Thyroid Associated Ophthalmopathy
Peking University People's Hospital 54
Testing effectiveness (Phase 2)Study completedNCT01868997
What this trial is testing

Teprotumumab (RV 001) Treatment in Patients With Active Thyroid Eye Disease

Who this might be right for
Thyroid Associated OphthalmopathiesThyroid-Associated Ophthalmopathy
Amgen 88
Early research (Phase 1)Study completedNCT01061788
What this trial is testing

A Trial of AMG 479, Everolimus (RAD001) and Panitumumab in Patients With Advanced Cancer - QUILT-3.007

Who this might be right for
Advanced Solid Tumors, Non-small Cell Lung Cancer
Jeffrey Clarke 43
Large-scale testing (Phase 3)Active Not RecruitingNCT05276063
What this trial is testing

A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye DiseaseGraves OrbitopathyEndocrine System Diseases+9 more
Sling Therapeutics, Inc. 90
Load More Results